RedHill Biopharma Ltd. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 85.03%100.00%46.94%66.06%64.09%42.68%42.39%46.06%47.03%60.31%
EBT Margin -1,550.00%-90.41%3,900.00%48,462.50%90,966.67%150,883.95%763,800.00%31,401.98%1,457.45%476.58%700.97%79.55%-113.98%-115.97%366.25%-102.80%
EBIT Margin -1,683.33%-197.83%-34,230.43%56,500.00%89,766.67%151,796.41%733,400.00%30,240.59%1,297.03%470.47%686.71%98.95%-94.61%-69.33%193.45%-181.69%
EBITDA Margin -1,683.33%-197.83%-34,230.43%56,500.00%89,766.67%151,796.41%733,400.00%30,240.59%1,297.03%470.47%686.71%98.95%-113.98%-115.97%366.25%-174.38%
Operating Margin -1,683.33%-197.83%-34,230.43%56,500.00%89,766.67%151,796.41%733,400.00%30,240.59%1,297.03%470.47%686.71%98.95%-94.61%-69.33%193.45%-181.69%
Net Margin -1,550.00%-90.41%3,900.00%48,462.50%90,966.67%150,883.95%763,800.00%31,401.98%1,457.45%476.58%700.97%79.55%-113.98%-115.97%366.25%-102.80%
FCF Margin -186.30%-20,395.65%-42,468.75%-70,300.00%-174,351.30%-594,666.67%-28,062.38%-1,120.91%-412.50%-650.41%-76.11%-75.98%-47.55%-548.71%-116.60%
Efficiency
Inventory Average 0.90M1.44M4.20M7.11M9.35M7.70M4.02M
Assets Average 20.14M17.22M21.60M47.84M70.52M65.78M59.88M68.25M127.17M180.71M170.03M90.96M20.55M
Equity Average 42.54M61.39M53.88M48.13M55.59M36.93M11.37M-19.76M-23.17M-1.31M
Invested Capital 25.01M60.08M62.70M45.06M52.85M63.82M95.25M92.50M66.82M11.65M7.33M
Asset Utilization Ratio 0.000.000.000.000.000.060.140.090.510.470.360.070.39
Leverage & Solvency
Interest Coverage Ratio 16.831.980.966.10769.4327.80103.7881.45674.96235.5198.634.99-4.87-1.011.32-7.11
Debt to Equity -0.270.320.200.170.130.1932.23M-37.70M12.65M0.145.879.42-2.38-14.38M
Debt Ratio 0.450.460.73
Equity Ratio 0.870.900.840.790.820.810.080.05-0.300.09-0.26
Times Interest Earned 16.831.980.966.10769.4327.80103.7881.45674.96235.5198.634.99-4.87-1.011.32-7.11
Valuation
Enterprise Value -12.56M38.56M-12.73M117.34M96.10M91.42M98.55M176.81M131.41M247.76M90.77M-13.63M-1.65M1.88M
Market Capitalization 56.96M123.48M118.85M132.96M132.53M213.33M172.20M284.98M120.72M8.96M4.66M7.92M
Return Ratios
Return on Sales -15.50%-0.90%39.00%484.63%909.67%314.02%14.57%4.77%7.01%0.80%-1.14%-1.16%3.66%-1.03%
Return on Capital Employed 0.54%0.47%0.96%0.79%0.75%1.18%-0.82%1.56%0.18%8.71%
Return on Assets 0.38%0.63%0.49%0.48%0.45%0.89%0.67%0.65%0.40%-0.54%-0.42%0.26%-0.40%
Return on Equity 0.54%0.52%1.08%0.83%0.79%1.39%-8.60%3.63%-1.03%6.33%